Imactiv-3D: Evaluation by imaging of the molecular activity in pre-clinical phases

A MODULAR AND FULLY CUSTOMIZABLE SERVICE FOR THE 3D QUANTITATIVE EVALUATION OF THE ACTIVITY OF YOUR COMPOUNDS

The leitmotif of the Imactiv-3D company is to meet the challenges of evaluation of active molecules:

• Understanding the mechanisms of action of molecules of interest
• Assess their activity at the pre-clinical phase in predictive biological 3D models
• Reduce the risk of failure of candidate molecules at the clinical stage

Imactiv-3D supports pharmas and biotech companies in their development strategy, study or research on innovative and reliable predictive models to help them in their decision making.

Imactiv-3D relies for this on three complementary expertise:
• In the use of commercially available 3D models, the management of your own models or samples, or the development of custom innovative 3D models,
• In the exploitation of 3D models and tissue imaging equipments at the forefront of technology, for the visualization and artwork of your samples (3D Models, tissues, organs)
• In the development of 3D image characterization methods to yield the objective and quantitative assessment of the effectiveness of compounds in preclinical phase.

Read more…

Tél : +33 5 82 99 10 09